MS

Merck KGaA carves into MS R&D after a string of setbacks
Fierce Biotech
Mon, 02/23/15 - 10:16 am
Merck KGaA
MS
multiple sclerosis
R&D
Alkermes says its more tolerable Tecfidera rival is ready for pivotal challenge
Fierce Biotech
Mon, 02/9/15 - 05:59 pm
Alkermes
ALKS 8700
MS
multiple sclerosis
Biogen Idec
Tecfidera
Teva Pharmaceutical's Strategy Proves to be Brilliant
Motley Fool
Fri, 02/6/15 - 05:51 pm
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
Acorda cautiously steps forward with a drug to spur remyelination in MS
Fierce Biotech
Mon, 02/2/15 - 07:52 am
Acorda Therapeutics
MS
multiple sclerosis
remylination
rHIgM22
Google, Biogen Work Together on Multiple Sclerosis Research
Bloomberg
Wed, 01/28/15 - 08:28 am
Google
Biogen Idec
MS
multiple sclerosis
U.S. Supreme Court rules for Teva in over multiple sclerosis drug patent
Yahoo/Reuters
Tue, 01/20/15 - 11:34 am
Teva Pharmaceuticals
Supreme Court
Copaxone
patents
MS
multiple sclerosis
Biogen issues early data on potential game-changing MS drug. Investors shrug.
Bizjournals.com
Thu, 01/8/15 - 02:48 pm
Biogen Idec
MS
multiple sclerosis
anti-LINGO-1
The bright side to Sanofi's Lemtrada delay? Its support-to-sell marketing plan
Fierce Pharma Marketing
Wed, 12/24/14 - 09:31 am
Sanofi
Lemtrada
Genzyme
MS
multiple sclerosis
Biogen Straps Fitbits Onto MS Patients' Wrists
Bloomberg/Businessweek
Wed, 12/24/14 - 08:52 am
Biogen Idec
Fitbit
multiple sclerosis
MS
3 Reasons Biogen Idec Inc. Could Soar in 2015
Motley Fool
Fri, 12/12/14 - 08:50 am
Biogen Idec
Tecfidera
hemophilia B
MS
Alzheimer's disease
BIIB037
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
Yahoo
Wed, 12/3/14 - 08:13 am
Genzyme
MS
multiple sclerosis
Lemtrada
Novartis’s Gilenya Fails to Help Hard-to-Treat Form of MS
Bloomberg
Mon, 12/1/14 - 09:59 am
Novartis
Gilenya
MS
multiple sclerosis
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Fierce Pharma Marketing
Tue, 11/18/14 - 11:01 am
Sanofi
Lemtrada
MS
multiple sclerosis
Genzyme’s Lemtrada Approved by the FDA
Yahoo/Businesswire
Sat, 11/15/14 - 09:34 am
Genzyme
Lemtrada
multiple sclerosis
MS
TEVA: Copaxone Patent Expiry Worries Are Overblown
Seeking Alpha
Wed, 11/12/14 - 08:44 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
patents
Teva expands laquinimod clinical development
Seeking Alpha
Tue, 11/4/14 - 02:21 pm
Teva Pharmaceutical
laquinimod
MS
multiple sclerosis
Saskatchewan to fund treatment with AUBAGIO® for Relapsing Remitting Multiple Sclerosis
Yahoo/CNW Group
Sat, 11/1/14 - 12:52 pm
Aubagio
multiple sclerosis
MS
Sanofi
Teva optimistic U.S. top court to rule in favour of MS drug patent
Yahoo/Reuters
Thu, 10/30/14 - 09:29 am
Teva Pharmaceutical
MS
multiple sclerosis
Copaxone
Supreme Court seems divided in patent dispute over best-selling multiple sclerosis drug
Yahoo/AP
Wed, 10/15/14 - 12:23 pm
Supreme Court
generics
multiple sclerosis
MS
Teva Pharmaceutical
Copaxone
Novartis reports positive data for Gilenya in key measures of MS disease activity
First Word Pharma
Fri, 09/12/14 - 10:22 am
Novartis
Gilenya
MS
multiple sclerosis

Pages